Because vascular endothelial growth factor (VEGF) is a key element in the formation of an immunosuppressive tumor microenvironment (TME) in addition to promoting tumor angiogenesis, VEGF blockade and ICI combination therapy may be more effective for HCC characterized by high vascularization [13]. Here, VEGFA is linked to neoplasm.